IDO1 and B-cell chronic lymphocytic leukemia: We have shown that monocytes from normal donors, cultured in the presence of a CLL-conditioned medium, upregulated Indoleamin-2,3 dioxygenase (IDO) and that IDO expression is significantly higher in monocytes from CLL patients than in monocytes from normal controls [1].